Skip to main content
Xspray Pharma logo

Xspray Pharma — Investor Relations & Filings

Ticker · XSPRAY ISIN · SE0023312764 LEI · 549300NGRQCNZ3X4L157 ST Manufacturing
Open in API
Filings indexed 254 across all filing types
Latest filing 2021-05-20 AGM Information
Country SE Sweden
Listing ST XSPRAY

About Xspray Pharma

https://xspraypharma.com/

Xspray Pharma is a pharmaceutical company that utilizes its patented technology platform to develop improved versions of marketed drugs, primarily focusing on Protein Kinase Inhibitors (PKIs) for cancer treatment. The company's core innovation lies in its ability to create stable, amorphous (non-crystalline) formulations of active pharmaceutical ingredients. This unique approach enables the development of product candidates that can bypass the secondary patents of original crystalline drugs, facilitating market entry upon the expiration of the primary substance patent. Xspray Pharma's products are designed to offer clinical benefits for patients compared to the original branded drugs and their subsequent generic equivalents.

Recent filings

Filing Released Lang Actions
Kommuniké från årsstämma i Xspray Pharma AB (publ)
AGM Information Classification · 99% confidence The document is titled "Kommuniké från årsstämma i Xspray Pharma AB (publ)" which translates to "Communiqué from the Annual General Meeting (AGM) in Xspray Pharma AB (publ)". The text details specific resolutions passed at the meeting held on May 20, 2021, including the approval of the 2020 financial statements, election of the board and auditor, decisions on remuneration, approval of incentive programs (LTI 2021), authorization for new share issues, and amendments to the articles of association. These are all typical outcomes and announcements following an AGM. Therefore, the correct classification is AGM Information (AGM-R).
2021-05-20 Swedish
Bulletin from the annual general meeting of Xspray Pharma AB (publ)
AGM Information Classification · 99% confidence The document explicitly states it is a "Bulletin from the annual general meeting of Xspray Pharma AB (publ)" and details the resolutions passed at the AGM on May 20, 2021. Key topics covered include the adoption of financial statements, election of board members and auditors, approval of remuneration reports, and resolutions regarding incentive programs and share authorizations. This content directly corresponds to the information typically summarized in an AGM resolution bulletin, fitting the definition for AGM Information (AGM-R). Although it mentions the adoption of the 2020 financial year results, the primary focus and structure are on the meeting's outcomes, not the full 10-K report itself.
2021-05-20 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'DELÅRSRAPPORT FÖRSTA KVARTALET 2021' (Interim Report First Quarter 2021) for Xspray Pharma AB. It contains detailed financial data, including income statements, cash flow analysis, and management commentary on business performance for the period of January to March 2021. It is a comprehensive quarterly report, not an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-06 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT FIRST QUARTER 2021' and contains detailed financial data, including net sales, loss before tax, earnings per share, and cash flow statements for the period of January to March 2021. It also includes a CEO message, business focus, and product portfolio analysis. This aligns perfectly with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-06 English
Kallelse till årsstämma i Xspray Pharma AB (publ)
AGM Information Classification · 99% confidence The document is titled "Kallelse till årsstämma i Xspray Pharma AB (publ)" which translates to "Notice of Annual General Meeting in Xspray Pharma AB (publ)". It details the procedures for voting via advance voting (poströstning) due to COVID-19 restrictions, lists the required attendance criteria (share register date, voting deadline), and presents a detailed agenda (dagordning) covering the election of the chairman, board members, auditors, approval of remuneration, and proposals regarding incentive programs and amendments to the articles of association. These elements are characteristic of a formal notice for an Annual General Meeting (AGM). The closest matching category is AGM Information (AGM-R), as this document serves as the official notice and material for the AGM.
2021-04-20 Swedish
Notice of annual general meeting of Xspray Pharma AB (publ)
AGM Information Classification · 100% confidence The document explicitly begins with the title "Notice of annual general meeting of Xspray Pharma AB (publ)" and details the procedures for shareholders to participate via advance voting due to the COVID-19 pandemic. It outlines the agenda, which includes the election of the chairman, board members, auditors, and resolutions on remuneration and incentive programs. This content is characteristic of a formal notice summoning shareholders to an Annual General Meeting (AGM). Therefore, the correct classification is AGM-R (AGM Information).
2021-04-20 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.